Reactive Oxygen Species Regulation Across Retinitis Pigmentosa Animal Models: A 25-Year Systematized Review

Rafael de Freitas Azevedo-Repossi1,2, Rafael Brito3, Marcelo Cossenza4

  • 1Laboratory of Gene Therapy and Viral Vector, Biophysics Graduate Program, Carlos Chagas Filho Institute of Biophysics, Universidade Federal Do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.

PubMed

Insights

Reactive oxygen species (ROS) play a key role in inherited retinal diseases like retinitis pigmentosa (RP). This review analyzes ROS in RP animal models, revealing common pathways like mitochondrial dysfunction and model-specific antioxidant responses.

Area of Science:

  • Ophthalmology
  • Genetics
  • Cell Biology

Background:

  • Retinitis pigmentosa (RP) is an inherited retinal disorder causing progressive photoreceptor degeneration and vision loss.
  • Limited treatment options for RP are due to the diverse genetic mutations involved.
  • Identifying common mechanisms in photoreceptor degeneration is crucial for RP research.

Purpose of the Study:

  • To systematically review and analyze data on reactive oxygen species (ROS) in animal models of retinitis pigmentosa over the past 25 years.
  • To aggregate and discuss findings related to ROS across various RP models.
  • To identify shared mechanisms and model-specific differences in ROS involvement and highlight research gaps.

Main Methods:

  • Systematic literature search for studies on ROS in RP animal models.
  • Analysis of data from the last 25 years.
  • Aggregation and discussion of findings, comparing commonalities and differences across models.

Main Results:

  • Consistent involvement of oxidative stress and ROS in photoreceptor degeneration across different RP models.
  • Pivotal role of mitochondrial dysfunction identified as a common mechanism.
  • Variations in antioxidant responses were observed, depending on the specific genetic mutation.

Conclusions:

  • Oxidative stress and ROS are central to RP pathogenesis, with mitochondrial dysfunction being a key shared pathway.
  • Understanding model-specific differences in ROS and antioxidant responses is essential.
  • These insights can guide future research towards novel therapeutic targets for RP, focusing on oxidative stress pathways.